Search the Newsreel

Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Swedish Orphan Biovitrum Stock Is Back In Focus Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after a new partnership with Innate Pharma …

Tidewater Renewables (TSX:LCFS) Stock Price Faces Earnings Quality Questions

Novo Holdings A/S (COAG) discloses 9.0% beneficial stake in Hemab Therapeutics

Novo Holdings A/S, an investment firm owned by the Novo Nordisk Foundation, has disclosed a 9.0% beneficial stake in Hemab Therapeutics Holdings, Inc., equating to 4,180,550 shares of common stock. Novo Holdings A/S holds sole voting and dispositive power over these shares. The filing …

Companhia De Saneamento Basico Do Estado De Sao Paulo (SBS) (Q2 2026) Earnings Call Highlights: ...

This article first appeared on GuruFocus. Adjusted Net Revenue: Grew 9.4% year over year, reflecting tariff adjustments and customer expansion. Adjusted EBITDA: Totaled BRL3.5 billion, down 2.3% year over year, with an EBITDA margin of 58.3%. Adjusted Net Income: Reached BRL1.2 billion, with the …

Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott's non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic …

A Look at Nabors Industries Ltd (NBR) After 3.1% Gain -- GF Value $52.09 vs Price $94.17

Nabors Industries Ltd (NBR) shares rose 3.1% to $94.17, reaching a 73.4% year-to-date increase, but GuruFocus's GF Value™ estimates the stock is 80.8% overvalued at $52.09. The company has an average GF Score™ of 56/100, with strengths in growth but weaknesses in profitability and …

Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ

CEMEX CPO: Modest Margin Strength Is Expected To Support Higher Future P/E

CEMEX's fair value has been decreased by 2.97% to MX$25.40, driven by adjusted assumptions in their financial model, including a higher discount rate and lower revenue growth. The company is also facing an antitrust investigation from the European Commission related to construction chemicals in …

2 Reasons to Like ABBV and 1 to Stay Skeptical

2 Reasons to Like ABBV and 1 to Stay Skeptical AbbVie has followed the market's trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.7% to $249.64 per share while the index has gained …

Lowered 2026 EPS Outlook and Rebounding Demand Could Be A Game Changer For Charles River (CRL)

Abeona Therapeutics (ABEO) Stock Faces Early Launch Strain Despite Revenue Traction

Babcock & Wilcox (BW) Is Up 9.8% After Data Center FastPower Deal And Q2 Profit Return

Athira Pharma (NASDAQ:LONA) Announces Quarterly Earnings Results

Athira Pharma (NASDAQ:LONA) reported quarterly earnings of ($0.80) per share, significantly beating the consensus estimate of ($1.90). Following the announcement, shares rose 1.4% to $7.98. Analysts maintain a "Moderate Buy" rating with a $16 price target, and institutional investors hold 57.12% of the company's …

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

On July 29, AbCellera Biologics Inc. (NASDAQ:ABCL) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its proprietary TCE platform to lead discovery, while Vertex will …

Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely?

This article analyzes Absci's financial health, specifically its cash burn rate and cash reserves, to assess its ability to fund operations and future growth. It examines the company's current cash runway, which is estimated to be over two years based on recent expenditures. The …

Berkshire Hathaway Boosted Alphabet, Delta Stakes in 2nd Quarter, Sold Bank of America

Berkshire’s Alphabet stake—consisting of the search giant’s voting and nonvoting shares—rose about 80% in the quarter to 106 million shares, reflecting a purchase directly from Alphabet in June and open-market buys, based on a 13-F report with the Securities and Exchange Commission late Friday. …

Berkshire Boosted Alphabet, Delta Stakes in 2nd Quarter, Sold Bank of America

Berkshire’s Alphabet stake—consisting of the search giant’s voting and nonvoting shares—rose about 80% in the quarter to 106 million shares, reflecting a purchase directly from Alphabet in June and open-market buys, based on a 13-F report with the Securities and Exchange Commission late Friday. …

Two Seas Capital discloses 5.4% Sable Offshore Corp. (SOC) position in Schedule 13G

The $120 billion market for coveted pre-IPO stock enters its scaling era

Mike Kemp/Getty Images Individual investors' unprecedented degree of access to private stock has created a $120 billion market, igniting yet another land grab by Wall Street firms and other big institutions. An increasing number of players, including Morgan Stanley and Charles Schwab, in the …

BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares

BioNexus Gene Lab Corp (BGLC) announced that its CEO and director, Tan Lee Su-Leng, received a fully vested stock award of 338,709 common shares. These shares, granted under the company's 2025 Equity Incentive Plan for completed services, were valued at $1.55 per share based …

BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award

BioNexus Gene Lab Corp director Bin Abdul Hamid Muhammad Azrul received a fully vested equity award of 32,258 common shares on August 13, 2026. The award, valued at $1.55 per share, was granted under the company’s 2025 Equity Incentive Plan for completed services, with …

BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award

BioNexus Gene Lab Corp (BGLC) director Low Jook Yuen received a fully vested stock award of 16,129 shares of common stock on August 13, 2026, for services rendered. This equity compensation, granted under the company's 2025 Equity Incentive Plan, had no cash consideration and …

Alphabet Just Borrowed $25 Billion, and $2.5 Billion of It Isn't Due Until 2066

Key Points The ten-tranche offering closed Monday, with coupons running from 4.5% on notes due 2028 to 6.5% on notes due 2066. Alphabet's long-term debt reached $98 billion at midyear, up from about $47 billion at the start of 2026, before this sale added …

Asia Pacific Wire & Cable Corporation (APWC) Reports Q2 2026 Numbers

Asia Pacific Wire & Cable Corporation (APWC) reported a significant decline in profitability for Q2 2026, with basic and diluted EPS falling to $0.01 from $0.03 in the prior year, despite an 8.0% increase in revenue to $136.6M. The company's net income was $781,000, …

Under Abel’s leadership for six months, Berkshire Hathaway significantly increased its stake in Google, with Class A shares rising to become one of the top five holdings; the company also boosted its positions in airline and real estate stocks in Q2.

Under Ted Weschler's management, Berkshire Hathaway substantially increased its stake in Google's Class A shares, making it one of the top five holdings within six months of Greg Abel's leadership. The company also notably expanded its investments in airline and real estate sectors during …

Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding

Berkshire Hathaway (BRK-A, BRK-B), under new CEO Greg Abel, increased its Alphabet position, making the Google parent its third-largest U.S.-listed equity holding by market value, behind Apple (AAPL) and American Express (AXP). According to a new filing, Berkshire held roughly 106 million Alphabet shares, …

Berkshire Hathaway expands Alphabet stake and trims bank exposure in Q2

Investing.com -- Berkshire Hathaway (NYSE:BRKb) aggressively expanded its stake in Alphabet Inc (NASDAQ:GOOGL) during the second quarter, signaling a deepening conviction in the technology giant's strategic trajectory. According to the Omaha-based conglomerate's latest 13F filing, the firm added tens of millions of shares across …

Low-Power Bluetooth Chips: Silicon Labs Introduced Its Bluetooth Low Energy System-On-Chip

Silicon Labs has introduced the BG2B, a new Series 2 Bluetooth Low Energy system-on-chip designed for compact, battery-powered IoT devices. This chip utilizes the company's lowest-power Bluetooth architecture to extend battery life, incorporates Secure Vault security, and features advanced Bluetooth Channel Sounding capabilities aligned …

Swedish Orphan Biovitrum (OM:SOBI) Stock Looks Strong On Returns But Fully Priced On Earnings

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Swedish Orphan Biovitrum has delivered a strong share price run over the past five years, yet its current valuation checks lean expensive rather …

Perceptive Advisors discloses 7.3% SAB Biotherapeutics (SABS) stake via Master Fund

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 7.3% in SAB Biotherapeutics (SABS). The Master Fund directly holds 6,627,501 shares, representing this percentage based on 90,986,368 shares outstanding as of August 3, 2026. All …

LeonaBio Q2 Results: EPS beats estimate, losses narrow 55% YoY

Jabil Inc. stock underperforms Friday when compared to competitors

Shares of Jabil Inc. (JBL) fell 1.94% on Friday, closing at $363.10. This underperformance occurred during a generally poor trading session where the S&P 500 Index and Dow Jones Industrial Average also declined. The stock's drop ended a three-day winning streak for Jabil Inc.

Berkshire Hathaway boosts Alphabet to a top three holding, ups Delta and housing bets

Berkshire Hathaway sharply increased its stake in Alphabet in the second quarter, vaulting the Google parent into its three biggest stock holdings. The sprawling conglomerate also added to the size of its investments in Delta Air Lines and various homebuilders. Berkshire, now operating under …

TNDM|Tandem Diabetes Care Inc|Price:22.617|Chg%:-0.513

Berkshire Hathaway bulks up on Alphabet, Delta Air, exits Constellation Brands, among Q2 trades (BRK.B:NYSE)

Berkshire Hathaway, under CEO Greg Abel, made significant portfolio changes in Q2 2026. The company established a new position in D.R. Horton, exited its holding in Constellation Brands, and increased its stakes in other companies including Alphabet and Delta Air. This rebalancing reflects the …

Whitefort Capital group reports 7.1% OmniAb (OABI) ownership in amended filing

Whitefort Capital Management, along with David Salanic and Joseph Kaplan, has reported a beneficial ownership of 7.1% in OmniAb, Inc. (OABI) through an amended Schedule 13G filing. This group beneficially owns 10,248,658 shares, representing 7.1% of OmniAb's outstanding shares as of June 30, 2026. …